Advocacy intelligence hub — real-time data for patient organizations
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Nacuity Pharmaceuticals, Inc. — PHASE1, PHASE2
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
FRANCESCA SIMONELLI
Eye Clinic of the University of Campania Luigi Vanvitelli, Naples, Italy
Carmen Ayuso
Instituto de Investigacion Sanitaria de la Fundacion Jimenez Diaz, Madrid, Spain
Xiangrong Kong
Johns Hopkins University
Isabelle Audo, Pr
Centre National d'Ophtalmologie des Quinze-Vingts
Jeffrey Weiss, MD
Coral Springs Florida, Vienna Austria, Dubai UAE
Jacque Duncan, MD
University of California, San Francisco